ePrints

Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer.

Lookup NU author(s): Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Dumez, H., Van Oosterom, A. T., Rothermel, J. D., Mull, R., Calvert, A. H.

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Oncology

Year: 2004

Volume: 22

Issue: 14 Supplement 1

Pages: 150 no. 2093

ISSN (print): 0732-183X

ISSN (electronic): 1527-7755

URL: http://meeting.ascopubs.org/cgi/content/abstract/22/14_suppl/2093

Notes: Originally presented at the 2004 ASCO Annual Meeting Proceedings. New Orleans, Los Angeles, USA.

Share